Cargando…

The role of molecular testing in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDA) is highly aggressive and has few treatment options. To personalize therapy, it is critical to delineate molecular subtypes and understand inter- and intra-tumoral heterogeneity. Germline testing for hereditary genetic abnormalities is recommended for all patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhen, David B., Safyan, Rachael A., Konick, Eric Q., Nguyen, Ryan, Prichard, Colin C., Chiorean, E. Gabriela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184226/ https://www.ncbi.nlm.nih.gov/pubmed/37197396 http://dx.doi.org/10.1177/17562848231171456

Ejemplares similares

The role of the folate pathway in pancreatic cancer risk
por: Chittiboyina, Shirisha, et al.
Publicado: (2018)

Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies
por: Chiorean, Elena Gabriela, et al.
Publicado: (2015)

The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer
por: Jia, Yanfei, et al.
Publicado: (2018)

Anti‐EGFR Therapy in Small Bowel Adenocarcinoma
por: Safyan, Rachael A., et al.
Publicado: (2018)

Real-World Assessment of Health Care Costs for Patients with Metastatic Pancreatic Cancer Following Initiation of First-Line Chemotherapy
por: Bullock, Andrea, et al.
Publicado: (2020)

Performance status dynamics during treatment with nab-paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer
por: Chiorean, E Gabriela, et al.
Publicado: (2018)

BRCA Mutations in Pancreas Cancer: Spectrum, Current Management, Challenges and Future Prospects
por: Wong, Winston, et al.
Publicado: (2020)

Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review
por: Chiorean, Elena Gabriela, et al.
Publicado: (2019)

Future role of endoscopic ultrasound in personalized management of pancreatic cancer
por: Ooi, Marie, et al.
Publicado: (2017)

Contribution of Environment and Genetics to Pancreatic Cancer Susceptibility
por: Hocevar, Barbara A., et al.
Publicado: (2014)

Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer
por: Goldstein, David, et al.
Publicado: (2020)

KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas
por: Diehl, Adam C, et al.
Publicado: (2022)

Identification of molecular mechanisms of glutamine in pancreatic cancer
por: Jia, Zhen-Yi, et al.
Publicado: (2017)

Positron emission tomography (PET) as a predictive measure in patients with metastatic pancreatic cancer and normal CA19-9 levels at baseline
por: Ramanathan, R. K., et al.
Publicado: (2016)

Editorial: Management of pancreatic cancer: Defining the targets for therapy
por: Nguyen, Nam Q.
Publicado: (2022)

Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
por: Chiorean, E Gabriela, et al.
Publicado: (2016)

Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
por: Chiorean, E Gabriela, et al.
Publicado: (2016)

Molecular Mechanisms Underlying the Role of MicroRNAs in the Chemoresistance of Pancreatic Cancer
por: Garajová, Ingrid, et al.
Publicado: (2014)

Molecular Pathways Controlling Autophagy in Pancreatic Cancer
por: New, Maria, et al.
Publicado: (2017)

Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence
por: Dreyer, Stephan B., et al.
Publicado: (2022)

The role of microbiome in pancreatic cancer
por: Li, Jenny Jing, et al.
Publicado: (2021)

The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer
por: Dreyer, Stephan B., et al.
Publicado: (2023)

The Finite Element Method Applied to a Problem of Blood Flow in Vessels
por: Nuţ, Gabriela, et al.
Publicado: (2012)

Molecular Subtyping and Precision Medicine for Pancreatic Cancer
por: Froeling, Fieke E. M., et al.
Publicado: (2021)

Molecular Targeted Intervention for Pancreatic Cancer
por: Mohammed, Altaf, et al.
Publicado: (2015)

The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective
por: Brocco, Davide, et al.
Publicado: (2020)

TRIM21 is a novel regulator of Par-4 in colon and pancreatic cancer cells
por: Nguyen, Jeffrey Q., et al.
Publicado: (2016)

Molecular Pathology of Pancreatic Cancer
por: Karamitopoulou, Eva
Publicado: (2022)

Role of pancreatic stellate cells in chemoresistance in pancreatic cancer
por: McCarroll, Joshua A., et al.
Publicado: (2014)

The Role of Notch Signaling and Leptin-Notch Crosstalk in Pancreatic Cancer
por: Harbuzariu, Adriana, et al.
Publicado: (2018)

Multiparametric MRI Features of Breast Cancer Molecular Subtypes
por: Szep, Madalina, et al.
Publicado: (2022)

PAXgene Fixation for Pancreatic Cancer: Implications for Molecular and Surgical Pathology
por: DeCoste, Ryan, et al.
Publicado: (2022)

The role of genetic testing in management of hereditary chronic pancreatitis
por: Walker, Nicholas Faure, et al.
Publicado: (2013)

Molecular Mechanism of Pancreatic Stellate Cells Activation in Chronic Pancreatitis and Pancreatic Cancer
por: Jin, Guihua, et al.
Publicado: (2020)

Role of erlotinib in the management of pancreatic cancer
por: Starling, Naureen, et al.
Publicado: (2006)

The Emerging Role of miRNAs for the Radiation Treatment of Pancreatic Cancer
por: Nguyen, Lily, et al.
Publicado: (2020)

The Role of US in Depicting Axillary Metastasis in High-Risk Breast Cancer Patients
por: Pintican, Roxana, et al.
Publicado: (2021)

Role of emerging molecular markers in pancreatic cyst fluid
por: Al-Haddad, Mohammad
Publicado: (2015)

Screen-Printed Graphene/Carbon Electrodes on Paper Substrates as Impedance Sensors for Detection of Coronavirus in Nasopharyngeal Fluid Samples
por: Ehsan, Muhammad Ali, et al.
Publicado: (2021)

Exploring the Trend in the Use of Electroconvulsive Therapy (ECT), Modified ECT and Transcranial Magnetic Stimulation (TMS) in Northamptonshire Healthcare Trust
por: Tariq, Safyan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ravl6kock5tcqginn6nv537n6h